GlassScriptPhysician profile
Michael James Belsante
NPI 1710118682
$58,288.33
in general payments reported to CMS, 2019-2025
64 companies · $3,217 in 2025
The $3,217 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $16K · 2021: $2,987 · 2022: $8,596 · 2023: $11K · 2024: $5,238 · 2025: $3,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,190 · Education: $4,035 · Consulting Fee: $3,560 · Travel and Lodging: $2,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,189.67 |
| Education | $4,035.06 |
| Consulting Fee | $3,560.00 |
| Travel and Lodging | $2,341.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,176.37 | 2019-2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $10,188.18 | 2019-2025 | Upsylon, General - Therapies, Ams 800 Artificial Urinary Sphincter |
| Astellas Pharma US INC | $9,255.28 | 2019-2024 | Myrbetriq, Veozah |
| Axonics, INC. | $4,424.71 | 2020-2024 | Axonics, Bulkamid |
| Calyxo, INC. | $3,628.46 | 2022-2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $1,039.48 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $863.84 | 2021-2025 | |
| Neotract INC. | $802.30 | 2019-2020 | |
| Janssen Biotech, INC. | $779.13 | 2021-2025 | Erleada, Akeega, Balversa |
| Coloplast Corp | $694.58 | 2021-2025 | Coloplast Tfl Drive, Speedicath, Restorelle |
| Abbvie INC. | $602.45 | 2020-2025 | Botox |
| Myriad Genetic Laboratories, INC. | $599.92 | 2021-2025 | Prolaris |
| Procept Biorobotics Corporation | $599.45 | 2021-2025 | Aquabeam System |
| Laborie Medical Technologies Corp. | $579.85 | 2020-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Medtronic, INC. | $442.80 | 2021-2025 | Interstim, Altaviva |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $435.38 | 2020-2025 | Jelmyto |
| Angiodynamics, INC. | $325.57 | 2021-2022 | |
| Sn Holdings, LLC | $305.00 | 2023 | |
| Caldera Medical, INC | $289.44 | 2022 | |
| Srs Medical Systems, INC. | $276.12 | 2020-2021 | |
| Rochester Medical Corporation | $238.20 | 2021-2022 | |
| Allergan, INC. | $226.44 | 2020-2022 | |
| Teleflex LLC | $222.87 | 2021-2022 | |
| Antares Pharma, INC. | $219.19 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Tolmar, INC. | $200.71 | 2023-2025 | Eligard, Jatenzo |
| Dendreon Pharmaceuticals LLC | $196.01 | 2019-2025 | Provenge |
| Myovant Sciences INC. | $192.09 | 2021-2022 | |
| Urovant Sciences INC | $187.07 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $187.03 | 2019-2025 | Adstiladrin |
| Medtronic USA, INC. | $182.47 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $173.66 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $147.21 | 2019-2024 | Bard Urinary Drainage Bag |
| E.R. Squibb & Sons, L.L.C. | $120.19 | 2021 | |
| Merck Sharp & Dohme LLC | $118.32 | 2022-2025 | Keytruda, Welireg |
| Janssen Scientific Affairs, LLC | $112.93 | 2019 | |
| Axogen | $108.94 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $106.68 | 2019-2022 | |
| Clarus Therapeutics INC. | $103.30 | 2021 | |
| Stryker Corporation | $96.65 | 2025 | 1788 |
| Progenics Pharmaceuticals, INC. | $80.65 | 2022-2023 | Pylarify |
| Olympus America INC. | $65.28 | 2022-2025 | Itind System |
| Zyla Life Sciences, INC. | $58.53 | 2020 | |
| Blue Earth Diagnostics | $54.45 | 2021-2022 | |
| 180 Medical, INC. | $53.97 | 2021-2022 | |
| Amgen INC. | $50.40 | 2020-2021 | |
| Ambu INC. | $49.80 | 2021-2022 | |
| Valencia Technologies Corporation | $48.53 | 2025 | Ecoin Device Kit |
| Photocure INC | $43.83 | 2024-2025 | Cysview |
| Endo USA, INC. | $39.86 | 2024 | Xiaflex |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Millicent US INC | $34.62 | 2023 | Femring, Intrarosa |
| Inspire Medical Systems, INC. | $27.94 | 2025 | Inspire |
| Lsi Solutions INC | $23.41 | 2024 | Running Device, Ti-Knot, Jnw Urtrac |
| Innovation Technologies INC | $21.91 | 2025 | Irrisept |
| Palette Life Sciences, INC. | $20.72 | 2022 | |
| Hollister Incorporated | $20.53 | 2022 | |
| Bioprotect Medical, INC. | $19.12 | 2025 | Bioprotect Balloon Implant System |
| Halozyme INC | $18.81 | 2023 | |
| Azurity Pharmaceuticals, INC. | $16.63 | 2025 | Azmiro |
| Verity Pharmaceuticals INC. | $15.97 | 2023 | Trelstar |
| Aytu Biopharma, INC. | $15.11 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.70 | 2022 | |
| Rti Surgical, INC | $12.23 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$256,451.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Belsante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.